Bristol Myers Squibb today announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with active psoriatic ...
The global Phage MuA Transposase Market is entering a dynamic phase of expansion, offering transformative opportunities for ...
As with her counterpart at the London Stock Exchange Group in the UK, Adena Friedman, CEO at NASDAQ, is ready to stick her ...
The Northern Lights may be visible in the U.S. this Monday, following a geomagnetic storm forecast by space weather experts ...
Among end-user segments, the pharmaceutical industry remains the dominant force, forecasted to represent 40.7% of total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback